Issues related to corporate and international tax, including regarding Public Law 115-97, Tax Cuts and Jobs Act
Issues related to Puerto Rico
H.R. 7527, Medical Manufacturing, Economic Development, and Sustainability Act of 2020
H.R. 6930, Manufacturing API, Drugs, and Excipients (MADE) in America Act of 2020
Proposed Rule, Guidance Related to the Foreign Tax Credit, Clarification of Foreign-Derived Intangible Income
Issues related to OECD negotiations on the taxation of global income
H.R.5376, "Build Back Better Act 
S. 4783, Territory Economic Development Tax Credit Act S.1435 Affordable Prescriptions for Patients Act
H.R.2873 Affordable Prescriptions for Patients Through Promoting Competition Act
H.R. 2884 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act
S. 2428 False Claims Amendments Act of 2021
Mergers and acquisitions, no specific bill Biosimilars reimbursement issues, no specific bill 
H.R. 3, Prescription drug pricing issues
FDA issues, no specific bill 
Supply Chain Issues, no specific bill
Patent thickets/product hopping, no specific bill
Mergers/acquisitions, no specific bill
H.R. 19 Lower Costs, More Cures Act of 2021
H.R. 5260 Reduced Costs and Continued Cures Act
H.R.5376, "Build Back Better Act
Issues related to clinical trial diversity S. 99 The Medicare Drug Price Negotiation Act, issues related to international reference pricing and Part D redesign
H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act, issues related to international reference pricing and Part D redesign
S. 1943 and H.R. 3517, Issues related to DXA, osteoporosis
Issues related to international reference pricing 
Issues related to the 340B program, no specific bill
Reimbursement for biologics/biosimilars
Issues related to Medicare Part D redesign
Issues related to patient affordability issues, including copay cards, copay accumulators, National Benefit Payment Parameters
ESRD bundle, calcimimetic access, no specific bill 
H.R. 19 Lower Costs, More Cures Act of 2021, issues related to international reference pricing and Part D redesign
H.R. 5260 Reduced Costs and Continued Cures Act, issues related to international reference pricing and Part D redesign
S. 2428 False Claims Amendments Act of 2021
H.R. 5376 Build Back Better Act, issues related to international reference pricing and Part D redesign
H.R. 5801 HELP Copays Act
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid
136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
AMGEN, INC.
601 13th Street, NW, 11th Floor North, WASHINGTON, DC, 20005, US
JORDAN LYNN LAYSON L NICOLE CURRIE HELEN RHEE KIMBERLY LOVE JORDAN LYNN LAYSON HELEN RHEE GREGORY PORTNER L NICOLE CURRIE WILLIAM O'BRIEN VICTORIA BLATTER HOWARD MOON JESSE KERNS KIMBERLY LOVE JORDAN LYNN LAYSON WILLIAM O'BRIEN HELEN RHEE JESSE KERNS L NICOLE CURRIE GREGORY PORTNER VICTORIA BLATTER HOWARD MOON RUTH HOFFMAN KIMBERLY LOVE JORDAN LYNN LAYSON L NICOLE CURRIE GREGORY PORTNER HELEN RHEE JESSE KERNS VICTORIA BLATTER WILLIAM O'BRIEN HOWARD MOON RUTH HOFFMAN